. About Lilly 00x00Through investments in people, medicines and health systems, we aim to improve health in underserved communities in the U. New data show therapy reduced risk of hospitalizations and death by 00 percent - Second positive Phase 0 trial readout for bamlanivimab and etesevimab together - Results support use of bamlanivimab 000 mg and etesevimab. Lilly 00x00 initiatives include activities across three areas of impact: pipeline, programs and partnerships